Philadelphia chromosome-positive lymphoblastic lymphoma-Is it rare or underdiagnosed?
Lymphoblastic lymphomas
Philadelphia chromosome-positive
Journal
Hematology/oncology and stem cell therapy
ISSN: 2589-0646
Titre abrégé: Hematol Oncol Stem Cell Ther
Pays: Saudi Arabia
ID NLM: 101468532
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
09
01
2018
revised:
15
04
2018
accepted:
14
05
2018
pubmed:
19
6
2018
medline:
27
3
2021
entrez:
19
6
2018
Statut:
ppublish
Résumé
Lymphoblastic lymphomas (LBLs) are neoplasms of precursor B and T cells; they are considered in the same spectrum as precursor B and T cell acute lymphoblastic leukemia (ALL). The World Health Organization classification classifies both LBL and ALL as one disease entity. While chromosome abnormalities are well defined with all of their therapeutic and prognostic implications in ALL, these are not well studied in LBL. Here, we describe a case of Philadelphia chromosome-positive LBL and review the available literature regarding this entity.
Identifiants
pubmed: 29913129
pii: S1658-3876(18)30063-3
doi: 10.1016/j.hemonc.2018.05.007
pii:
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
242-243Informations de copyright
Copyright © 2018 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. All rights reserved.